Literature DB >> 4023641

Experience with the latissimus dorsi flap.

I M Nielsen, M Lassen, B N Gregersen, C Krag.   

Abstract

A review of 65 applications of the latissimus dorsi flap based on the thoraco-dorsal vessels to recipient sites in the head and neck area (10), on the torso (22), in the upper extremity (9) and in the lower extremity (24) in 62 patients with malignancies (28) and congenital deformities (6) is presented. Thirty-five flaps were transplanted with microsurgical vascular technique, while 30 flaps were pedicled. Vascular thrombosis at the anastomotic site was seen in 4/35 free tissue transplants and was successfully managed in 3 cases with an overall survival rate of 97% in this group, while all pedicled flaps survived. Healing complications including haematomas and wound infections were related to the nature of the recipient site and most commonly seen in the lower leg after resection of infected bone. In 3 cases leg amputations were performed within 6 months after the reconstruction, while 6 patients had secondary operations for tibial pseudoarthroses. Donor site morbidity was insignificant, without permanent, functional losses. It is concluded, that the thoracodorsal unit is a versatile and safe flap for reconstructive purposes.

Entities:  

Mesh:

Year:  1985        PMID: 4023641     DOI: 10.3109/02844318509052865

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  2 in total

1.  Peripherally Inserted Central Catheters as Potential Risk Factors for Failure in Pedicled Latissimus Dorsi Flaps.

Authors:  Johnny Ionut Efanov; Gabriel Bouhadana; Michel A Danino
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-21

2.  RECONSTRUCTION FOLLOWING EXTENSIVE TUMOR RESECTION OF THE PELVIC AND SCAPULAR GIRDLE: A REPORT OF TWO CASES.

Authors:  Juliana Corrêa Dallagnol; Rosyane Rena de Freitas; André Luiz Soares Crivellaro; Glauco José Pauka Mello; Mário Armani Neto; Geraldo de Freitas Filho
Journal:  Rev Bras Ortop       Date:  2015-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.